Healthcare >> CEO Interviews >> May 3, 2004
DAVID A. CHAZANOVITZ joined Cambridge Heart, Inc., in October 2000 as
President and Chief Executive Officer. He has over 30 years' experience
in the sales, marketing and general management of medical products
businesses, ranging from early stage device companies to larger, more
established businesses. He has been active in developing products,
marketing and selling to many different medical specialties including
electrophysiology, interventional cardiology and radiology, pediatric
cardiology, gastroenterology and general surgery. Prior to joining
Cambridge Heart, Mr. Chazanovitz worked as a Divisional President for
NMT Medical, initially with total responsibility for establishing a
startup effort to develop a new cardiac technology and more recently as
President of their Neurosciences Division. Mr. Chazanovitz has also held
the position of President of several divisions of C.R. Bard, Inc.,
including Bard Ventures, Bard Electrophysiology Division and USCI
Angiography Division. Mr. Chazanovitz earned a Bachelor of Science
degree in Biology from City College of New York and an MBA in Marketing
from Long Island University. Profile
main technological thrust?
Mr. Chazanovitz: Cambridge Heart was founded in 1990 and became a public
company in 1996. It
